Journal of Addiction Medicine

Article	Citations
Methamphetamine Use in Psychiatric Emergency Services and Among Asian American and Pacific Islander Populations	65
A Naturalistic Study of Individuals Involved in the Justice System Who Experienced Both Formulations of Extended-release Buprenorphine	65
Oral Health Risks of Transmucosal Buprenorphine: Commentary on Tuan et al. and Zheng et al.	59
The Pharmacological Management of Ketamine Use Disorder: A Systematic Review	55
Characteristics of Ongoing Clinical Trials for Cocaine Use Disorder Registered on Global Clinical Trial Databases	47
Perinatal Substance Use-Related Content at Major Addiction Scientific Conferences: An Analysis of Oral Presentation Sessions	47
Generative Artificial Intelligence Tools in Medicine Will Amplify Stigmatizing Language	42
Differences in Self-identification of Opioid Overdose Risk and Naloxone Perceptions Between Therapeutic and Nontherapeutic Opioid Populations	40
GLP-1 RA Medication Associations With Hazardous Alcohol Drinking Reductions in Patients With Overweight or Obesity: A Prospective Observational Study	38
Synthetic Cathinone–Induced Myocarditis and Psychosis: A Case Report	35
Rapid Transition to Buprenorphine in a Patient With Methadone-Related QTc Interval Prolongation	34
Managing Benzodiazepine Withdrawal—The Emperor’s New Clothes	33
Initiating Long-acting Injectable Naltrexone: Procedure for a Second Attempt After a First Attempt Fails	33
Patient Satisfaction With Standard Methadone and Flexible Buprenorphine/Naloxone Models of Care: Results From a Pragmatic Randomized Controlled Clinical Trial	32
A Brief Intervention on Alcohol Use Disorder Is Associated With Treatment Access for Inpatients With Alcohol-associated Liver Disease	31
A Plea From People Who Use Drugs to Clinicians: New Ways to Initiate Buprenorphine Are Urgently Needed in the Fentanyl Era	31
Neonatal Outcomes after Medications for Opioid Use Disorder during Pregnancy in a State Women’s Prison Facility, 2016–2019	27
Low Dose Buprenorphine Induction With Full Agonist Overlap in Hospitalized Patients With Opioid Use Disorder: A Retrospective Cohort Study	24
Responses to a “Typical” Morning Dose of Kratom in People Who Use Kratom Regularly: A Direct-Observation Study	23
Associations between Patient Experience and Addiction Treatment Facility Services: Results of the Addiction Treatment Locator, Assessment, and Standards Surveys	22
Initiatives to Support the Transition of Patients With Substance Use Disorders From Acute Care to Community-based Services Among a National Sample of Nonprofit Hospitals	22
Use of Cannabinoids by People Who Consume Kratom in the United States	22
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder	22
Adolescent Tobacco/Nicotine Use and the Potential Role of Contingency Management-based Interventions	21
Identifying Areas to Improve Care and Support Parent-Child Relationships From the Perspective of Pregnant and Parenting People in Recovery	20

Clinical and Demographic Characteristics of Hospitalized Patients With Xylazine-related Wounds	20
Approaches for Managing Benzodiazepine Dependence Arising From Use of the Adulterated Opioid Supply: A Delphi Technique	19
Low-dose Buprenorphine Initiation in Pregnancy: A Systematic Review	18
Drive Time to Addiction Treatment Facilities Providing Contingency Management across Rural and Urban Census Tracts in 6 US States	18
Individuals Dispensed Buprenorphine in the United States Before and After Federal Policy Changes Aimed at Increasing Access	17
High Primary COVID-19 Vaccine Series Completion by People Who Inject Drugs When Colocating Services at a Syringe Services Van	17
Subcutaneous Extended-release Buprenorphine Depot Misdiagnosed as an Abscess Resulting in Incision and Drainage and Disruption of Opioid Use Disorder Treatment	17
Stigmatizing Language in Substance Use-related International Classification of Diseases Codes	17
Complicating Factors Surrounding Concurrent Use of Kratom and a Novel 7-hydroxymitragynine Product Among a Participant Enrolled in a Kratom Clinical Trial	16
Outcomes in Subsequent Pregnancies of Individuals With Opioid Use Disorder Treated in Multidisciplinary Clinic in Prior Pregnancy	15
Fentanyl Test Strips for Harm Reduction: A Scoping Review	15
A Peer Recovery Coach Intervention for Hospitalized Patients with Opioid Use Disorder: A Pilot Randomized Controlled Trial	14
Trauma Prevalence and Its Association With Health-related Quality of Life in Pregnant Persons With Opioid Use Disorder	14
Provider Perceptions Toward Extended-Release Buprenorphine for Treatment of Opioid Use Disorder	14
Implementation of Telemedicine Delivery of Medications for Opioid Use Disorder in Pennsylvania Treatment Programs During COVID-19	14
Feasibility of Emergency Department–based Fentanyl Test Strip Distribution	14
Testing and Case Rates of Gonorrhea, Chlamydia, Syphilis, and HIV among People with Substance Use Disorders in the Veterans Health Administration	14
Public Xylazine Awareness and Support for Policies and Initiatives to Address the Xylazine Threat Among US Adults	13
Adapting Contingency Management for Hospitalized Patients with Stimulant Use Disorder	13
Assessing Childhood Maltreatment Exposure in Patients Without and With a Diagnosis of Substance Use Disorder	13
Climate Change and the Opioid Epidemic	13
Xylazine Use Among People Who Inject Drugs, Philadelphia 2022	13
Integrative Analysis of Proteome-wide Association Studies and Functional Enrichment Analysis to Identify Genes and Chemicals Associated with Alcohol Dependence	12
Medical Detoxification for Nonopioid Substances Is Associated With Lower Likelihood of Subsequent Linkage to Substance Use Disorder Treatment	12
Opioid Settlements: The Role for Addiction Medicine in Guiding Effective Spending	12
The Effect of Dehydroepiandrosterone Administration during Rehabilitation on White Matter Integrity Among Individuals With Polysubstance Use Disorder	12
Systematic Review of Obstetric and Child Outcomes of Prenatal Exposure to Inhalants in the Context of a Use Disorder	12
Exploring Family Planning Perspectives Among Men Receiving Medications for Opioid Use Disorder: Implications for Service Development	12
The Association Between Perceived Injustice and Opioid Craving in Patients With Chronic Pain: The Mediating Role of Daily Pain Intensity, Negative Affect, and Catastrophizing	12
Current State of Perioperative Buprenorphine Management—A National Provider Survey	11
A Hospital-based Managed Alcohol Program in a Canadian Setting	11
Online Narcotics Anonymous: An Option for Addressing Methamphetamine Use Disorder	11
Insurance-related Risk Factors for Leaving Against Medical Advice after Opioid Overdose: A Cross-sectional Study Using Electronic Health Records	10
Xylazine Test Strip Use Among People Who Use Drugs in New York State	10
Estimating the Prevalence of Using Suspected Counterfeit Medications in the General Population	10
The Use of Pattern Recognition to Augment Traditional Monitoring in the Prevention of Opioid Overdose Harm	10
Response to: “Prevalence of Kratom Use Disorder among Kratom Consumers”	10
Clinical Presentations and Treatment of Phenibut Toxicity and Withdrawal: A Systematic Literature Review	10
Letter in Reply	10
Retention and Overdose Risk among Patients Receiving Substance Use Disorder Treatment, Mental Health Care and Peer Recovery Support: A Longitudinal Analysis	9
Integration of Substance Use Disorder Services in Veterans Affairs Primary Care Clinics Serving Homeless Women	9
Evidence of Designer Benzodiazepine Use in Routine Healthcare Urine Drug Specimens	9
Increasing Initiation of Medications for Opioid Use Disorder Through Recovery Coaches: The Role of Implementation Setting	9
The Use of a Single Dose of Phenobarbital for Inpatient Management of Benzodiazepine Withdrawal: A Case Report	9
48-hour Induction of Transdermal Buprenorphine to Sublingual Buprenorphine/Naloxone: The IPPAS Method	9
ASAM/AAAP Clinical Practice Guideline (CPG) for Stimulant Use Disorder (StUD) Management: Commentary on Research Priorities	9
The Difficulties in Finding the Relevant Associations Between Internet Gaming Disorder (IGD) and the Incidence of Suicide-Related Ideation and Behaviors in College Students	9
Aripiprazole Is Not Effective for Abstinence or Decreased Use in Alcohol and Stimulant Use Disorders in Patients Without Psychiatric Comorbidities: A Systematic Review	9
Investigating Healthcare Provider Bias Toward Patients Who Use Drugs Using a Survey-based Implicit Association Test: Pilot Study	9
Retention With Medication for Opioid Use Disorder: The Role of the Primary Care Relationship	9

Evidence of “Repeated Admission Bias” Among Those Who Use Injection Drugs Across 2 Decades of US Treatment Admissions: 2000–2020	9
Discordance Between Self-reported and Biologically Tested Exposure to Fentanyl Among People at Risk of Opioid Overdose	9
Secondary Analysis of Agreement Between Negative Timeline Follow Back Report and Negative Urine Toxicology in a Large Trial of Individuals with Opioid Use Disorder	9
Missed Opportunities: Substance Use Hotline Operator Uncertainty of State Buprenorphine Prescribing via Telemedicine	8
A Scoping Review of Youth Overdose Prevention Interventions	8
Simultaneous Management of Alcohol Use Disorder and Liver Disease: A Systematic Review and Meta-analysis	8
Complexities in Assessing Pregnancy-related Outcomes Among Patients Receiving Interdisciplinary Treatment for an Opioid Use Disorder	8
Chronic Pain Associated Alcohol Use Disorder Among Participants in a Small Clinical Trial	8
Examining Racial/Ethnic and Income Disparities on Tobacco Product Use Among US Adults Within Wave 5 of the PATH Study	8
N-acetylcysteine Efficacy on Cocaine Base Paste Use Disorder: A Randomized Double-blind Placebo-controlled Clinical Trial	8
Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine	8
Addiction Services for Veterans: Opportunities in Acute Care	8
Barriers and Facilitators to Accessing Opioid Agonist Therapy for Street-involved Adolescents and Young Adults in Vancouver	8
Kratom Use Among Pregnant and Lactating Individuals With Substance Use Disorder	8
Reply to: “Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine”	8
Wound Care Capacity of the Addiction Workforce in the Setting of Xylazine	8
The Shifting Landscape of a Fentanyl Adulterant: Moving From Xylazine to Medetomidine	8
Three-year Retention Rates With Office-based Treatment of Buprenorphine for Opioid Use Disorder in a Private Family Medicine Practice	8
Perceptions of Overdose Response Hotlines and Phone Application Services Among Women and Gender-diverse Individuals Who Use Drugs in Canada: A Qualitative Study	8
Response to "Two Clinical Insights on Methamphetamine Withdrawal at a Safety-net Hospital"	8
Direct Induction of Buprenorphine Extended-Release: A Case Report	7
Sociodemographic and Health Factors of the Alcohol Treatment-seeking Population in New South Wales, Australia	7
Using Machine Learning to Predict Treatment Adherence in Patients on Medication for Opioid Use Disorder	7
Anhedonia and Substance Use Disorders by Type, Severity, and With Mental Health Disorders	7
“Just Be There”: Desired Partner Behaviors Among Pregnant People Living With Opioid Use Disorder, a Qualitative Study	7
Implementation of Specialty Tobacco Use Disorder Services in a Community Health Setting: Support for Enhanced Prescription Practices	7
Readmissions Among Patients With Surgically Managed Drug Use Associated-Infective Endocarditis Before and After the Implementation of an Addiction Consult Team: A Retrospective, Observational Analysis	7
Gabapentin Use During Pregnancy and Lactation With and Without Concurrent Opioid Exposure: Considerations and Future Directions	7
Validating the Waterpipe Addiction, Craving, and Anticipation Scale: An Exploratory Factor Analysis	7
48-hour Induction of Transdermal Buprenorphine to Extended-release Buprenorphine	7
Artificial Intelligence and Stigma in Addiction Research: Insights From the HEALing Communities Study Coalition Meetings	7
Enhancing Patient Choice: Using Self-administered Intranasal Naloxone for Novel Rapid Buprenorphine Initiation	7
Heterogeneity in Prescription Opioid Misuse Motives by Age in Adolescents and Young Adults in the United States	7
Feasibility of a Brief Intervention to Decrease Harmful Alcohol Use Among Methadone Maintenance Treatment Clients in Shanghai: A Randomized Controlled Trial	7
Predictors of the Rate of Illicit Fentanyl Metabolism in a Cohort of Pregnant Individuals	7
Predictive Models to Assess Risk of Persistent Opioid Use, Opioid Use Disorder, and Overdose	7
Stigmatizing Terminology for Outcomes and Processes (STOP) in Alcohol Research: A Meta-epidemiologic Assessment of Language Used in Clinical Trial Publications	7
Z-Drug Use and Benzodiazepine Use and Misuse Among LGB Populations: The Role of Psychological Distress	7
Concerns for Discharge of Persons Who Inject Drugs Home With Central Venous Catheters: A Letter to the Editor	7
Prevalence of Kratom Use Disorder Among Kratom Consumers	7
Examining the Primary Care Experience of Patients With Opioid Use Disorder: A Qualitative Study	7
Satisfaction With Opioid Agonist Treatment: The Compelling Need for Multidimensional, Patient-centered, Patient-reported Experience Measures	7
Response to: “Chronic Pain Associated Alcohol Use Disorder Among Participants in a Small Clinical Trial”	7
Cannabis and Cannabinoids for Treating Pain: What Are the Data?	7
Increased Risks of Major Cardiac Adverse Events in Stimulant Use Disorder as Compared With Other Substance Use Disorders: A Propensity-score Matching Cohort Study	7
Supervised Disulfiram Should Be Considered First-line Treatment for Alcohol Use Disorder	6
Response to Martins et al.	6
Parosmia Is Positively Associated With Problematic Drinking, as Is Phantosmia With Depressive Symptoms	6
The Impact of Frequency of Cannabis Use on Hypertensive Disorders During Pregnancy	6
Effectiveness and Safety of Varenicline for Smoking Cessation: An Overview and Meta-analysis	6
Regular Kratom (Mitragyna speciosa Korth.) Use and Its Association With Endoplasmic Reticulum Stress Response	6
Predictors of Treatment Completion in an Inpatient Substance Use Treatment Service in India	6
The Concept of Treatment-Refractory Addiction: Implications for Addiction Treatment Systems and Research	6
Injection Drug Use and Healthcare Utilization in Patients Newly Diagnosed With HIV	6
Health Care Service Presence, Social Vulnerability, and Opioid Overdose Rate Acceleration: A United States, County-level Analysis, 2020–2022	6
Identifying Barriers to Buprenorphine Treatment for Patients with Opioid Use Disorder Among Anesthesiologists and Pain Practitioners: A Survey Study	6
Response to the Federation of State Physician Health Program's Commentary	6
Medications for Alcohol Use Disorder Among Birthing People With an Alcohol-related Diagnosis	6
False-Positive Phosphatidylethanol Results Due to Blood Transfusion and Implications in the Process of Liver Transplantation Selection	6
Fentanyl Absorption, Distribution, Metabolism, and Excretion: Narrative Review and Clinical Significance Related to Illicitly Manufactured Fentanyl	6
Changes in Rates of Hospitalizations due to Cannabis Harms in Ontario, Canada Before the Legalization of Nonmedical Cannabis: Retrospective Population-level Study Between 2003 and 2017	6
Disruption of Opioid Treatment Program Services Due to an Extreme Weather Event: An Example of Climate Change Effects on the Health of Persons Who Use Drugs	6
Medication Initiation, Patient-directed Discharges, and Hospital Readmissions Before and After Implementing Guidelines for Opioid Withdrawal Management	6
Patterns of Substance Use During Early Pregnancy and Associations With Behavioral Health Characteristics	6
Feasibility of an Inpatient Split-Dose Rapid Methadone Induction Protocol for Pregnant Individuals	6
Challenges of Drug Testing in Addiction Treatment	6
Development and Validation of a High-sensitivity Rapid Xylazine Dipstick for Clinical Urine Testing	6
Nonopioid Substance Use among Patients Who Recently Initiated Office-based Buprenorphine Treatment	6
Disparities in Buprenorphine Administration for Opioid Use Disorder in the Emergency Department	6
The First 100 Days: The Trump Administration and Changes to Addiction Policy	6
Participant Experiences of a Quit Smoking Attempt Through Either Nicotine Replacement Therapy (NRT) Methods or the Use of an E-cigarette	5
Outpatient Rapid Titration of Slow Release Oral Morphine for the Treatment of Opioid Use Disorder in a Canadian Setting: A Case Series	5
Risk of Cannabis Use Disorder in Chronic Pain: Longitudinal Links to Pain Outcomes	5
Universal Postpartum Naloxone Provision: A Harm Reduction Quality Improvement Project	5
Expert Views on State Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder: A Qualitative Analysis of an Online Modified Delphi Process	5
Safety and Efficacy of Rapid Methadone Titration for Opioid Use Disorder in an Inpatient Setting: A Retrospective Cohort Study	5
A Critique of Phenobarbital Tapers With Buprenorphine or Methadone Initiations	5
Precipitated Opioid Withdrawal Treated With Ketamine in a Hospitalized Patient: A Case Report	5
Transition to Extended-release Buprenorphine Injectable Within Seven Days for Opioid Use Disorder Treatment: A Scoping Narrative	5
Privacy, Care-seeking, and Stigma: A Qualitative Investigation of Patient Perspectives on Sharing Substance Use Disorder Treatment Records	5

Naloxone Use During Pregnancy—Data From 26 US Jurisdictions, 2019–2020	5
Explaining Racial-ethnic Disparities in the Receipt of Medication for Opioid Use Disorder during Pregnancy	5
Circumstances Around Cigarette Use after Enforced Abstinence From Smoking in an American Prison	5
Prescribing Psychostimulants for the Treatment of Stimulant Use Disorder: Navigating the Federal Legal Landscape	5
Buprenorphine-naloxone Versus Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy	5
Use of Practices to Reduce of Sudden Unexpected Infant Death Among Caregivers of Opioid Exposed Newborns	5
The Impact of High-Potency Synthetic Opioids on Pharmacotherapies for Opioid Use Disorder: A Scoping Review	5
Opioid Use Disorder Among the Economically Disadvantaged in the Rural South	5
Predictors of Risky Sexual Behaviors Among Female Adolescents and Young Adults Seeking Withdrawal Management Treatment: A Lifestyle-routine Activities Theory Approach	5
Reductions in World Health Organization Risk Drinking Level Are Associated With Reductions in Alcohol Use Disorder Diagnosis and Criteria: Evidence From an Alcohol Pharmacotherapy Trial	5
Microdose Induction of Buprenorphine in a Patient Using Tianeptine	5
2024 ASAM Annual Conference Poster Abstracts	5
A Brief Screening and Assessment Tool for Opioid Use in Adults: Results from a Validation Study of the Tobacco, Alcohol, Prescription Medication, and Other Substances Tool	5
Quetiapine: A Novel Additive to the Illicit Heroin Supply in Los Angeles	5
Does Labetalol Trigger False Positive Drug Testing Results?	5
The Relationship Between Reductions in WHO Risk Drinking Levels During Treatment and Subsequent Healthcare Costs for the ACTIVE Workgroup	5
The American Society of Addiction Medicine Clinical Practice Guideline Development Methodology	5
Exploring Preferences for Communication and Care Among Hospitalized Patients With Opioid Use Disorder: A Qualitative Descriptive Study	5
A Retrospective Cohort Study of Oral Antimicrobial Therapy Offers in Hospitalized People Who Inject Drugs Who Elect for Self-directed Discharge	5
Self-reported Xylazine Experiences: A Mixed-methods Study of Reddit Subscribers	5
Community Pharmacists’ Knowledge and Perceptions of Buprenorphine for Patients with Opioid Use Disorder	5
Privacy and Digital Health: Causes for Concern and a Way Forward	5